The use of enteral nutrition in the management of Crohn's disease in adults

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue 4_suppl, 2005, Pages S166-S172

  Dray, X ^a   Marteau, Phillipe ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BUTYRIC ACID; CORTICOSTEROID; DOCOSAHEXAENOIC ACID; FISH OIL; GLUTAMINE; ICOSAPENTAENOIC ACID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LIPID; MESALAZINE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; STEROID; TRANSFORMING GROWTH FACTOR BETA2; VITAMIN;

ADULT; ARTICLE; CORTICOSTEROID THERAPY; CROHN DISEASE; DIET THERAPY; DRUG EFFICACY; ENTERIC FEEDING; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; LIPID COMPOSITION; LOW MICROPARTICLE DIET; MEDIATOR; META ANALYSIS; PARENTERAL NUTRITION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SYMPTOM; ULCERATIVE COLITIS; WOUND HEALING; ELEMENTAL DIET; REVIEW; STANDARD; TASTE; TREATMENT OUTCOME;

ADULT; CROHN DISEASE; ENTERAL NUTRITION; FOOD, FORMULATED; HUMANS; PATIENT COMPLIANCE; PROBIOTICS; TASTE; TREATMENT OUTCOME;

EID: 27744523070     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/01486071050290S4S166     Document Type: Article

References (48)

1. Sandborn WJ, Feagan BG. Review article: mild to moderate Crohn's disease-defining the basis for a new treatment algorithm. Aliment Pharmacol Ther. 2003; 18: 263-277.
2. Cosnes J, Carbonnel F, Beaugerie L, Gendre J. Malnutrition and nutritional support in Crohn's disease: a prospective evaluation (abstract). Clin Nutr. 1997; 16: P35.
3. Goh J, O'Morain CA. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003; 17: 307-320.
4. Lashner BA, Evans AA, Hanauer SB. Preoperative total parenteral nutrition for bowel resection in Crohn's disease. Dig Dis Sci. 1989; 34: 741-746.
5. Barbe L, Carbonnel F, Carrat F, et al. Effets de la nutrition artificielle préopératoire dans les résections intestinales pour maladie de Crohn. Gastroenterol Clin Biol. 1996; 20: 852-857.
6. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995; 19: 356-364.
7. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995; 108: 1056-1067.
8. Messori A, Trallori G, D'Albasio G, et al. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol. 1996; 31: 267-272.
9. Malchow H. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol. 1997; 25: 653-658.
10. Lindor K, Fleming C, Burnes J, et al. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroides in active Crohn's disease. Mayo Clinic Proc. 1992; 67: 328-333.
11. Gorard D, Hunt J, Payne-Jones J, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut. 1993; 34: 1198-1202.
12. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed). 1984; 288: 1859-1862.
13. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study IV. Gastroenterology. 1991; 101: 881-888.
14. Gonzalez-Huix F, de Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut. 1993; 34: 778-782.
15. Seidman E, Lohoues M, Turgeon J, et al. Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long-term results. Gastroenterology. 1991; 1991: 250A.
16. Seidman E, Griffiths A, Jones A, et al. Semielemental diet versus prednisone in the treatment of active Crohn's disease: a prospective steroid controlled trial. Gut. 1993; 34: 778-782.
17. Royal D, Jeejeebhoy K, Baker J, et al. Comparison of amino acid versus peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut. 1994; 35: 783-787.
18. Park R, Galloway A, Danesh B, Russell R. Double-blind controlled trial of elemental and polymeric diets as primary therapy in active Crohn's disease. Eur J Gastroenterol Hepatol. 1991; 3: 483-490.
19. Rigaud D, Cosnes J, Le Quintrec Y, et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut. 1991; 32: 1492-1497.
20. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000; 14: 281-289.
21. Ramirez S, Moreau J, Hebuterne X, et al. Tolerance, modalités de prescription et efficacité d'une nutrition orale par un mélange spécifique polymerique dans la maladie de Crohn chez l'adulte. Nutr Clin Metabol. 2004; 18: 551.
22. Gassull MA, Mañé J, Pedrosa E, Cabre E. Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease? JPEN J Parenter Enteral Nutr. 2005; 29: S179-S1 83.
23. McKenzie S, Baker M, Buffinton G, Doe W. Evidence of oxidant-induced injury to epithelial cells during inflammaroty bowel disease. J Clin Invest. 1996; 98: 136-141.
24. Geerling B, Badart-Smook A, Stockbrugger R, Brummer R. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998; 67: 919-926.
25. Miralles-Barrachina O, Savoye G, Belmonte-Zalar I, et al. Low levels of glutathion in endoscopic biopsoes of patients with Crohn's colitis: the role of malnutrition. Clin Nutr. 1999; 18: 313-317.
26. Buffington G, Doe W. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Rad Res. 1995; 22: 131-143.
27. Aghdassi E, Wendland B, Steinhart A, et al. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. Am J Gastro. 2003; 98: 348-353.
28. Chen K, Okuma T, Okamura K, et al. Glutamine-supplemented parenteral nutrition improves gut mucosa integrity and function in endotoxemic rats. JPEN J Parenter Enteral Nutr. 1994; 18: 167-171.
29. Kudsk KA, Wu Y, Fukatsu K, et al. Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. JPEN J Parenter Enteral Nutr. 2000; 24: 270-275.
30. Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000; 30: 78-84.
31. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut. 2000; 47: 397-403.
32. Delzenne N. Oligosaccharides: state of the art. Proc Nutr Soc. 2003; 2003: 177-182.
33. Cook S, Sellin J. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998; 12: 499-507.
34. Vermia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest. 2003; 33: 244-248.
35. Moreau N, Martin L, Toquet C, et al. Restoration of the integrity of rat-colonic mucosa by resistant starch, but not by fructooligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br J Nutr. 2003; 90: 75-85.
36. Mitsuyama K, Saiki T, Kanauchi O, et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther. 1998; 12: 1225-1230.
37. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 1999; 94: 427-433.
38. Marteau P, Vrese M, Cellier C, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73 (suppl): 430S-436S.
39. Gibson G. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr. 1998; 80: S209-S212.
40. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebi-otic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut. 2004; 53: 1610-1616.
41. Marteau P, Seksik P. Probiotiques et maladies inflammatoires de l'intestin. Gastroenterol Clin Biol. 2001; 21: C94-C97.
42. Guslandi M, Mezzi G, Sorghi M, Testoni P. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci. 2000; 45: 1462-1464.
43. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of postoperative recurrence of Crohn's disease: a randomized controlled study vs mesalamine. Gastroenterology. 2000; 118: G4179.
44. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002; 51: 405-409.
45. Lomer M, Thompson R, Powell J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc. 2002; 61: 123-130.
46. Powell J, Ainley C, Harvey R, et al. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut. 1996; 38: 390-395.
47. Lomer M, Harvey R, Evans S, et al. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol. 2001; 13: 101-106.
48. Jones S, Shannon H, Srivastava E, Haboubi N. A novel approach to a patient with Crohn disease and a high stoma output: a missed opportunity? Scand J Gastroenterol. 2004; 39: 398-400.